nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—CHRM3—muscle of abdomen—ovarian cancer	0.048	0.231	CbGeAlD
Cyproheptadine—HTR2A—vein—ovarian cancer	0.0219	0.106	CbGeAlD
Cyproheptadine—HTR2B—myometrium—ovarian cancer	0.00809	0.0389	CbGeAlD
Cyproheptadine—HTR2B—uterine cervix—ovarian cancer	0.00629	0.0303	CbGeAlD
Cyproheptadine—HTR2B—decidua—ovarian cancer	0.006	0.0288	CbGeAlD
Cyproheptadine—HTR2B—endometrium—ovarian cancer	0.00569	0.0274	CbGeAlD
Cyproheptadine—SLC6A2—decidua—ovarian cancer	0.00533	0.0256	CbGeAlD
Cyproheptadine—HTR2B—uterus—ovarian cancer	0.00525	0.0252	CbGeAlD
Cyproheptadine—HRH1—myometrium—ovarian cancer	0.00517	0.0249	CbGeAlD
Cyproheptadine—HTR2C—female reproductive system—ovarian cancer	0.00502	0.0241	CbGeAlD
Cyproheptadine—CHRM1—female reproductive system—ovarian cancer	0.00474	0.0228	CbGeAlD
Cyproheptadine—HTR2B—female reproductive system—ovarian cancer	0.00472	0.0227	CbGeAlD
Cyproheptadine—SLC6A2—gonad—ovarian cancer	0.00469	0.0226	CbGeAlD
Cyproheptadine—Neuritis—Epirubicin—ovarian cancer	0.00439	0.00556	CcSEcCtD
Cyproheptadine—Leukopenia—Chlorambucil—ovarian cancer	0.00438	0.00554	CcSEcCtD
Cyproheptadine—HTR2B—vagina—ovarian cancer	0.00426	0.0205	CbGeAlD
Cyproheptadine—CHRM3—female reproductive system—ovarian cancer	0.00424	0.0204	CbGeAlD
Cyproheptadine—Convulsion—Chlorambucil—ovarian cancer	0.00424	0.00537	CcSEcCtD
Cyproheptadine—SLC6A2—female reproductive system—ovarian cancer	0.00419	0.0201	CbGeAlD
Cyproheptadine—HTR2A—embryo—ovarian cancer	0.00415	0.02	CbGeAlD
Cyproheptadine—Neuritis—Doxorubicin—ovarian cancer	0.00406	0.00514	CcSEcCtD
Cyproheptadine—HRH1—epithelium—ovarian cancer	0.00406	0.0195	CbGeAlD
Cyproheptadine—Confusional state—Chlorambucil—ovarian cancer	0.00402	0.0051	CcSEcCtD
Cyproheptadine—HRH1—uterine cervix—ovarian cancer	0.00402	0.0193	CbGeAlD
Cyproheptadine—Hepatic failure—Docetaxel—ovarian cancer	0.00392	0.00497	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00391	0.00495	CcSEcCtD
Cyproheptadine—Leukopenia—Topotecan—ovarian cancer	0.0039	0.00493	CcSEcCtD
Cyproheptadine—CHRM3—female gonad—ovarian cancer	0.00386	0.0186	CbGeAlD
Cyproheptadine—HRH1—decidua—ovarian cancer	0.00383	0.0184	CbGeAlD
Cyproheptadine—Leukopenia—Melphalan—ovarian cancer	0.00382	0.00483	CcSEcCtD
Cyproheptadine—Anorexia—Chlorambucil—ovarian cancer	0.0038	0.00482	CcSEcCtD
Cyproheptadine—Convulsion—Melphalan—ovarian cancer	0.00369	0.00468	CcSEcCtD
Cyproheptadine—HRH1—endometrium—ovarian cancer	0.00364	0.0175	CbGeAlD
Cyproheptadine—Dyspepsia—Chlorambucil—ovarian cancer	0.00351	0.00445	CcSEcCtD
Cyproheptadine—Sweating increased—Paclitaxel—ovarian cancer	0.0035	0.00443	CcSEcCtD
Cyproheptadine—Oedema—Melphalan—ovarian cancer	0.00348	0.00441	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Topotecan—ovarian cancer	0.00348	0.00441	CcSEcCtD
Cyproheptadine—Decreased appetite—Chlorambucil—ovarian cancer	0.00347	0.00439	CcSEcCtD
Cyproheptadine—Fatigue—Chlorambucil—ovarian cancer	0.00344	0.00436	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Topotecan—ovarian cancer	0.00343	0.00435	CcSEcCtD
Cyproheptadine—CHRM3—testis—ovarian cancer	0.00342	0.0165	CbGeAlD
Cyproheptadine—Thrombocytopenia—Melphalan—ovarian cancer	0.00341	0.00431	CcSEcCtD
Cyproheptadine—Tachycardia—Melphalan—ovarian cancer	0.0034	0.0043	CcSEcCtD
Cyproheptadine—HTR2A—epithelium—ovarian cancer	0.00339	0.0163	CbGeAlD
Cyproheptadine—Anorexia—Topotecan—ovarian cancer	0.00339	0.00429	CcSEcCtD
Cyproheptadine—SLC6A2—testis—ovarian cancer	0.00338	0.0163	CbGeAlD
Cyproheptadine—Vertigo—Vinorelbine—ovarian cancer	0.00335	0.00424	CcSEcCtD
Cyproheptadine—Leukopenia—Vinorelbine—ovarian cancer	0.00333	0.00422	CcSEcCtD
Cyproheptadine—Pollakiuria—Paclitaxel—ovarian cancer	0.00332	0.00421	CcSEcCtD
Cyproheptadine—Anorexia—Melphalan—ovarian cancer	0.00332	0.0042	CcSEcCtD
Cyproheptadine—Palpitations—Vinorelbine—ovarian cancer	0.00329	0.00417	CcSEcCtD
Cyproheptadine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00329	0.00416	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00328	0.00416	CcSEcCtD
Cyproheptadine—Weight increased—Paclitaxel—ovarian cancer	0.00327	0.00414	CcSEcCtD
Cyproheptadine—Hypotension—Melphalan—ovarian cancer	0.00325	0.00412	CcSEcCtD
Cyproheptadine—Paraesthesia—Topotecan—ovarian cancer	0.00319	0.00404	CcSEcCtD
Cyproheptadine—Urticaria—Chlorambucil—ovarian cancer	0.00317	0.00401	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00314	0.00398	CcSEcCtD
Cyproheptadine—Dyspepsia—Topotecan—ovarian cancer	0.00313	0.00396	CcSEcCtD
Cyproheptadine—Paraesthesia—Melphalan—ovarian cancer	0.00312	0.00396	CcSEcCtD
Cyproheptadine—Decreased appetite—Topotecan—ovarian cancer	0.00309	0.00391	CcSEcCtD
Cyproheptadine—DRD2—testis—ovarian cancer	0.00308	0.0148	CbGeAlD
Cyproheptadine—Fatigue—Topotecan—ovarian cancer	0.00306	0.00388	CcSEcCtD
Cyproheptadine—Dyspepsia—Melphalan—ovarian cancer	0.00306	0.00388	CcSEcCtD
Cyproheptadine—Constipation—Topotecan—ovarian cancer	0.00304	0.00385	CcSEcCtD
Cyproheptadine—Decreased appetite—Melphalan—ovarian cancer	0.00302	0.00383	CcSEcCtD
Cyproheptadine—HRH1—female reproductive system—ovarian cancer	0.00301	0.0145	CbGeAlD
Cyproheptadine—Fatigue—Melphalan—ovarian cancer	0.003	0.0038	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00298	0.00377	CcSEcCtD
Cyproheptadine—Tachycardia—Vinorelbine—ovarian cancer	0.00297	0.00376	CcSEcCtD
Cyproheptadine—Feeling abnormal—Topotecan—ovarian cancer	0.00293	0.00371	CcSEcCtD
Cyproheptadine—Anorexia—Vinorelbine—ovarian cancer	0.0029	0.00367	CcSEcCtD
Cyproheptadine—Asthenia—Chlorambucil—ovarian cancer	0.00286	0.00363	CcSEcCtD
Cyproheptadine—Hypotension—Vinorelbine—ovarian cancer	0.00284	0.0036	CcSEcCtD
Cyproheptadine—Urticaria—Topotecan—ovarian cancer	0.00282	0.00357	CcSEcCtD
Cyproheptadine—HTR2A—gonad—ovarian cancer	0.00282	0.0136	CbGeAlD
Cyproheptadine—Weight increased—Docetaxel—ovarian cancer	0.00277	0.00351	CcSEcCtD
Cyproheptadine—Urticaria—Melphalan—ovarian cancer	0.00276	0.0035	CcSEcCtD
Cyproheptadine—HTR2B—lymph node—ovarian cancer	0.00276	0.0133	CbGeAlD
Cyproheptadine—HRH1—female gonad—ovarian cancer	0.00274	0.0132	CbGeAlD
Cyproheptadine—Diarrhoea—Chlorambucil—ovarian cancer	0.00273	0.00346	CcSEcCtD
Cyproheptadine—Paraesthesia—Vinorelbine—ovarian cancer	0.00273	0.00346	CcSEcCtD
Cyproheptadine—HRH1—vagina—ovarian cancer	0.00273	0.0131	CbGeAlD
Cyproheptadine—Photosensitivity—Epirubicin—ovarian cancer	0.00271	0.00343	CcSEcCtD
Cyproheptadine—Tinnitus—Paclitaxel—ovarian cancer	0.00268	0.0034	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00266	0.00337	CcSEcCtD
Cyproheptadine—Jaundice—Docetaxel—ovarian cancer	0.00265	0.00335	CcSEcCtD
Cyproheptadine—Hepatic failure—Epirubicin—ovarian cancer	0.00265	0.00335	CcSEcCtD
Cyproheptadine—Decreased appetite—Vinorelbine—ovarian cancer	0.00264	0.00335	CcSEcCtD
Cyproheptadine—Fatigue—Vinorelbine—ovarian cancer	0.00262	0.00332	CcSEcCtD
Cyproheptadine—Constipation—Vinorelbine—ovarian cancer	0.0026	0.00329	CcSEcCtD
Cyproheptadine—Chills—Paclitaxel—ovarian cancer	0.00258	0.00327	CcSEcCtD
Cyproheptadine—Asthenia—Topotecan—ovarian cancer	0.00255	0.00323	CcSEcCtD
Cyproheptadine—Vomiting—Chlorambucil—ovarian cancer	0.00254	0.00321	CcSEcCtD
Cyproheptadine—Agranulocytosis—Docetaxel—ovarian cancer	0.00254	0.00321	CcSEcCtD
Cyproheptadine—Increased appetite—Epirubicin—ovarian cancer	0.00253	0.00321	CcSEcCtD
Cyproheptadine—HTR2A—female reproductive system—ovarian cancer	0.00252	0.0121	CbGeAlD
Cyproheptadine—Photosensitivity—Doxorubicin—ovarian cancer	0.00251	0.00317	CcSEcCtD
Cyproheptadine—Feeling abnormal—Vinorelbine—ovarian cancer	0.0025	0.00317	CcSEcCtD
Cyproheptadine—Asthenia—Melphalan—ovarian cancer	0.0025	0.00316	CcSEcCtD
Cyproheptadine—Tension—Paclitaxel—ovarian cancer	0.00246	0.00311	CcSEcCtD
Cyproheptadine—SLC6A2—lymph node—ovarian cancer	0.00245	0.0118	CbGeAlD
Cyproheptadine—Hepatic failure—Doxorubicin—ovarian cancer	0.00245	0.0031	CcSEcCtD
Cyproheptadine—Hepatitis—Docetaxel—ovarian cancer	0.00244	0.00309	CcSEcCtD
Cyproheptadine—HRH1—testis—ovarian cancer	0.00243	0.0117	CbGeAlD
Cyproheptadine—Nervousness—Paclitaxel—ovarian cancer	0.00243	0.00308	CcSEcCtD
Cyproheptadine—Diarrhoea—Topotecan—ovarian cancer	0.00243	0.00308	CcSEcCtD
Cyproheptadine—Urticaria—Vinorelbine—ovarian cancer	0.00241	0.00306	CcSEcCtD
Cyproheptadine—Diarrhoea—Melphalan—ovarian cancer	0.00238	0.00301	CcSEcCtD
Cyproheptadine—Diplopia—Epirubicin—ovarian cancer	0.00238	0.00301	CcSEcCtD
Cyproheptadine—Nausea—Chlorambucil—ovarian cancer	0.00237	0.003	CcSEcCtD
Cyproheptadine—Vision blurred—Paclitaxel—ovarian cancer	0.00236	0.00299	CcSEcCtD
Cyproheptadine—Dizziness—Topotecan—ovarian cancer	0.00235	0.00298	CcSEcCtD
Cyproheptadine—Tremor—Paclitaxel—ovarian cancer	0.00235	0.00297	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—ovarian cancer	0.00234	0.00297	CcSEcCtD
Cyproheptadine—Agitation—Paclitaxel—ovarian cancer	0.0023	0.00291	CcSEcCtD
Cyproheptadine—HTR2A—vagina—ovarian cancer	0.00228	0.011	CbGeAlD
Cyproheptadine—Vomiting—Topotecan—ovarian cancer	0.00226	0.00286	CcSEcCtD
Cyproheptadine—Vertigo—Paclitaxel—ovarian cancer	0.00225	0.00285	CcSEcCtD
Cyproheptadine—Syncope—Paclitaxel—ovarian cancer	0.00225	0.00284	CcSEcCtD
Cyproheptadine—Leukopenia—Paclitaxel—ovarian cancer	0.00224	0.00284	CcSEcCtD
Cyproheptadine—Rash—Topotecan—ovarian cancer	0.00224	0.00284	CcSEcCtD
Cyproheptadine—Dermatitis—Topotecan—ovarian cancer	0.00224	0.00283	CcSEcCtD
Cyproheptadine—Headache—Topotecan—ovarian cancer	0.00223	0.00282	CcSEcCtD
Cyproheptadine—Palpitations—Paclitaxel—ovarian cancer	0.00221	0.0028	CcSEcCtD
Cyproheptadine—Vomiting—Melphalan—ovarian cancer	0.00221	0.0028	CcSEcCtD
Cyproheptadine—Loss of consciousness—Paclitaxel—ovarian cancer	0.0022	0.00279	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—ovarian cancer	0.0022	0.00279	CcSEcCtD
Cyproheptadine—Rash—Melphalan—ovarian cancer	0.00219	0.00278	CcSEcCtD
Cyproheptadine—Dermatitis—Melphalan—ovarian cancer	0.00219	0.00278	CcSEcCtD
Cyproheptadine—Chills—Docetaxel—ovarian cancer	0.00219	0.00277	CcSEcCtD
Cyproheptadine—Asthenia—Vinorelbine—ovarian cancer	0.00218	0.00276	CcSEcCtD
Cyproheptadine—Convulsion—Paclitaxel—ovarian cancer	0.00217	0.00275	CcSEcCtD
Cyproheptadine—Nausea—Topotecan—ovarian cancer	0.00211	0.00267	CcSEcCtD
Cyproheptadine—Diarrhoea—Vinorelbine—ovarian cancer	0.00208	0.00263	CcSEcCtD
Cyproheptadine—Nausea—Melphalan—ovarian cancer	0.00207	0.00262	CcSEcCtD
Cyproheptadine—Confusional state—Paclitaxel—ovarian cancer	0.00206	0.00261	CcSEcCtD
Cyproheptadine—Oedema—Paclitaxel—ovarian cancer	0.00204	0.00259	CcSEcCtD
Cyproheptadine—HTR2A—testis—ovarian cancer	0.00203	0.00977	CbGeAlD
Cyproheptadine—Shock—Paclitaxel—ovarian cancer	0.00201	0.00255	CcSEcCtD
Cyproheptadine—Dizziness—Vinorelbine—ovarian cancer	0.00201	0.00255	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.002	0.00253	CcSEcCtD
Cyproheptadine—Tachycardia—Paclitaxel—ovarian cancer	0.002	0.00253	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00198	0.0025	CcSEcCtD
Cyproheptadine—Anorexia—Paclitaxel—ovarian cancer	0.00195	0.00247	CcSEcCtD
Cyproheptadine—Vomiting—Vinorelbine—ovarian cancer	0.00193	0.00245	CcSEcCtD
Cyproheptadine—Rash—Vinorelbine—ovarian cancer	0.00192	0.00243	CcSEcCtD
Cyproheptadine—Dermatitis—Vinorelbine—ovarian cancer	0.00191	0.00242	CcSEcCtD
Cyproheptadine—Hypotension—Paclitaxel—ovarian cancer	0.00191	0.00242	CcSEcCtD
Cyproheptadine—Headache—Vinorelbine—ovarian cancer	0.0019	0.00241	CcSEcCtD
Cyproheptadine—Syncope—Docetaxel—ovarian cancer	0.0019	0.00241	CcSEcCtD
Cyproheptadine—Leukopenia—Docetaxel—ovarian cancer	0.0019	0.00241	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—ovarian cancer	0.0019	0.0024	CcSEcCtD
Cyproheptadine—Palpitations—Docetaxel—ovarian cancer	0.00188	0.00238	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00188	0.00238	CcSEcCtD
Cyproheptadine—Weight increased—Epirubicin—ovarian cancer	0.00187	0.00237	CcSEcCtD
Cyproheptadine—Loss of consciousness—Docetaxel—ovarian cancer	0.00187	0.00236	CcSEcCtD
Cyproheptadine—Insomnia—Paclitaxel—ovarian cancer	0.00185	0.00234	CcSEcCtD
Cyproheptadine—Convulsion—Docetaxel—ovarian cancer	0.00184	0.00233	CcSEcCtD
Cyproheptadine—Paraesthesia—Paclitaxel—ovarian cancer	0.00184	0.00232	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—ovarian cancer	0.00183	0.00232	CcSEcCtD
Cyproheptadine—Somnolence—Paclitaxel—ovarian cancer	0.00182	0.0023	CcSEcCtD
Cyproheptadine—Nausea—Vinorelbine—ovarian cancer	0.00181	0.00229	CcSEcCtD
Cyproheptadine—Dyspepsia—Paclitaxel—ovarian cancer	0.0018	0.00228	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.0018	0.00227	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—ovarian cancer	0.00179	0.00226	CcSEcCtD
Cyproheptadine—Decreased appetite—Paclitaxel—ovarian cancer	0.00178	0.00225	CcSEcCtD
Cyproheptadine—HRH1—lymph node—ovarian cancer	0.00176	0.00848	CbGeAlD
Cyproheptadine—Fatigue—Paclitaxel—ovarian cancer	0.00176	0.00223	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—ovarian cancer	0.00176	0.00222	CcSEcCtD
Cyproheptadine—Constipation—Paclitaxel—ovarian cancer	0.00175	0.00221	CcSEcCtD
Cyproheptadine—Confusional state—Docetaxel—ovarian cancer	0.00175	0.00221	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00174	0.0022	CcSEcCtD
Cyproheptadine—Oedema—Docetaxel—ovarian cancer	0.00173	0.00219	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—ovarian cancer	0.00173	0.00219	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—ovarian cancer	0.00171	0.00217	CcSEcCtD
Cyproheptadine—Shock—Docetaxel—ovarian cancer	0.0017	0.00216	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Docetaxel—ovarian cancer	0.0017	0.00215	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—ovarian cancer	0.0017	0.00215	CcSEcCtD
Cyproheptadine—Tachycardia—Docetaxel—ovarian cancer	0.00169	0.00214	CcSEcCtD
Cyproheptadine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00168	0.00213	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00166	0.0021	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—ovarian cancer	0.00165	0.00209	CcSEcCtD
Cyproheptadine—Anorexia—Docetaxel—ovarian cancer	0.00165	0.00209	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—ovarian cancer	0.00165	0.00208	CcSEcCtD
Cyproheptadine—Urticaria—Paclitaxel—ovarian cancer	0.00162	0.00206	CcSEcCtD
Cyproheptadine—Hypotension—Docetaxel—ovarian cancer	0.00162	0.00205	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—ovarian cancer	0.00158	0.002	CcSEcCtD
Cyproheptadine—Insomnia—Docetaxel—ovarian cancer	0.00157	0.00198	CcSEcCtD
Cyproheptadine—Paraesthesia—Docetaxel—ovarian cancer	0.00156	0.00197	CcSEcCtD
Cyproheptadine—Somnolence—Docetaxel—ovarian cancer	0.00154	0.00195	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—ovarian cancer	0.00153	0.00194	CcSEcCtD
Cyproheptadine—Dyspepsia—Docetaxel—ovarian cancer	0.00153	0.00193	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—ovarian cancer	0.00152	0.00193	CcSEcCtD
Cyproheptadine—Decreased appetite—Docetaxel—ovarian cancer	0.00151	0.00191	CcSEcCtD
Cyproheptadine—Fatigue—Docetaxel—ovarian cancer	0.00149	0.00189	CcSEcCtD
Cyproheptadine—Constipation—Docetaxel—ovarian cancer	0.00148	0.00188	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—ovarian cancer	0.00148	0.00187	CcSEcCtD
Cyproheptadine—Asthenia—Paclitaxel—ovarian cancer	0.00147	0.00186	CcSEcCtD
Cyproheptadine—Feeling abnormal—Docetaxel—ovarian cancer	0.00143	0.00181	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—ovarian cancer	0.00142	0.0018	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—ovarian cancer	0.00141	0.00178	CcSEcCtD
Cyproheptadine—Diarrhoea—Paclitaxel—ovarian cancer	0.0014	0.00177	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—ovarian cancer	0.00139	0.00176	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—ovarian cancer	0.00137	0.00173	CcSEcCtD
Cyproheptadine—Dizziness—Paclitaxel—ovarian cancer	0.00135	0.00171	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—ovarian cancer	0.00135	0.00171	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—ovarian cancer	0.00132	0.00167	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—ovarian cancer	0.0013	0.00165	CcSEcCtD
Cyproheptadine—Vomiting—Paclitaxel—ovarian cancer	0.0013	0.00165	CcSEcCtD
Cyproheptadine—Rash—Paclitaxel—ovarian cancer	0.00129	0.00163	CcSEcCtD
Cyproheptadine—Dermatitis—Paclitaxel—ovarian cancer	0.00129	0.00163	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—ovarian cancer	0.00129	0.00163	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—ovarian cancer	0.00129	0.00163	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—ovarian cancer	0.00128	0.00163	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—ovarian cancer	0.00128	0.00162	CcSEcCtD
Cyproheptadine—Headache—Paclitaxel—ovarian cancer	0.00128	0.00162	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—ovarian cancer	0.00127	0.0016	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—ovarian cancer	0.00126	0.00159	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—ovarian cancer	0.00125	0.00158	CcSEcCtD
Cyproheptadine—Asthenia—Docetaxel—ovarian cancer	0.00124	0.00157	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—ovarian cancer	0.00124	0.00157	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—ovarian cancer	0.00122	0.00154	CcSEcCtD
Cyproheptadine—Nausea—Paclitaxel—ovarian cancer	0.00121	0.00154	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—ovarian cancer	0.00119	0.00151	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—ovarian cancer	0.00119	0.0015	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—ovarian cancer	0.00119	0.0015	CcSEcCtD
Cyproheptadine—Diarrhoea—Docetaxel—ovarian cancer	0.00119	0.0015	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—ovarian cancer	0.00118	0.00149	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—ovarian cancer	0.00117	0.00148	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—ovarian cancer	0.00117	0.00148	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—ovarian cancer	0.00116	0.00147	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—ovarian cancer	0.00115	0.00146	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—ovarian cancer	0.00115	0.00145	CcSEcCtD
Cyproheptadine—Dizziness—Docetaxel—ovarian cancer	0.00115	0.00145	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—ovarian cancer	0.00114	0.00145	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—ovarian cancer	0.00114	0.00144	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00113	0.00143	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—ovarian cancer	0.00111	0.00141	CcSEcCtD
Cyproheptadine—Vomiting—Docetaxel—ovarian cancer	0.0011	0.0014	CcSEcCtD
Cyproheptadine—Rash—Docetaxel—ovarian cancer	0.00109	0.00138	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—ovarian cancer	0.00109	0.00138	CcSEcCtD
Cyproheptadine—Dermatitis—Docetaxel—ovarian cancer	0.00109	0.00138	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—ovarian cancer	0.00109	0.00138	CcSEcCtD
Cyproheptadine—Headache—Docetaxel—ovarian cancer	0.00109	0.00137	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—ovarian cancer	0.00108	0.00137	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—ovarian cancer	0.00106	0.00135	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00106	0.00134	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—ovarian cancer	0.00106	0.00134	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—ovarian cancer	0.00106	0.00134	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—ovarian cancer	0.00105	0.00133	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00105	0.00132	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—ovarian cancer	0.00104	0.00132	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—ovarian cancer	0.00103	0.00131	CcSEcCtD
Cyproheptadine—Nausea—Docetaxel—ovarian cancer	0.00103	0.0013	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—ovarian cancer	0.00103	0.0013	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—ovarian cancer	0.00102	0.00129	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—ovarian cancer	0.00101	0.00128	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—ovarian cancer	0.00101	0.00128	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—ovarian cancer	0.001	0.00127	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—ovarian cancer	0.000978	0.00124	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—ovarian cancer	0.000971	0.00123	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—ovarian cancer	0.000963	0.00122	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—ovarian cancer	0.000961	0.00122	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—ovarian cancer	0.000952	0.00121	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—ovarian cancer	0.00094	0.00119	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—ovarian cancer	0.000932	0.00118	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—ovarian cancer	0.000929	0.00118	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—ovarian cancer	0.000925	0.00117	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000891	0.00113	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—ovarian cancer	0.000859	0.00109	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—ovarian cancer	0.000839	0.00106	CcSEcCtD
Cyproheptadine—Diarrhoea—Epirubicin—ovarian cancer	0.0008	0.00101	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—ovarian cancer	0.000776	0.000983	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—ovarian cancer	0.000773	0.000979	CcSEcCtD
Cyproheptadine—Protriptyline—ABCB1—ovarian cancer	0.000749	0.332	CrCbGaD
Cyproheptadine—Clozapine—CYP1B1—ovarian cancer	0.000747	0.331	CrCbGaD
Cyproheptadine—Vomiting—Epirubicin—ovarian cancer	0.000743	0.000941	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—ovarian cancer	0.00074	0.000937	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—ovarian cancer	0.000737	0.000933	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—ovarian cancer	0.000736	0.000932	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—ovarian cancer	0.000732	0.000927	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—ovarian cancer	0.000715	0.000906	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—ovarian cancer	0.000694	0.000879	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—ovarian cancer	0.000688	0.000871	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—ovarian cancer	0.000682	0.000863	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—ovarian cancer	0.000681	0.000863	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—ovarian cancer	0.000678	0.000858	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—ovarian cancer	0.000642	0.000813	CcSEcCtD
Cyproheptadine—Carbamazepine—ABCB1—ovarian cancer	0.000349	0.154	CrCbGaD
Cyproheptadine—Clozapine—ABCB1—ovarian cancer	0.000214	0.0949	CrCbGaD
Cyproheptadine—Amitriptyline—ABCB1—ovarian cancer	0.000199	0.0882	CrCbGaD
